nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Blood creatinine decreased—Zoledronate—osteoporosis	0.0333	0.0524	CcSEcCtD
Terlipressin—Abdominal cramps—Estropipate—osteoporosis	0.0151	0.0237	CcSEcCtD
Terlipressin—Abdominal cramps—Calcitriol—osteoporosis	0.0141	0.0223	CcSEcCtD
Terlipressin—Fluid overload—Pamidronate—osteoporosis	0.0123	0.0193	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—CALCR—osteoporosis	0.0121	0.0333	CbGpPWpGaD
Terlipressin—AVPR2—G alpha (s) signalling events—PTH1R—osteoporosis	0.0121	0.0333	CbGpPWpGaD
Terlipressin—Fluid overload—Conjugated Estrogens—osteoporosis	0.0108	0.017	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—MGLL—osteoporosis	0.0101	0.0277	CbGpPWpGaD
Terlipressin—Abdominal cramps—Conjugated Estrogens—osteoporosis	0.00996	0.0157	CcSEcCtD
Terlipressin—Cyanosis—Conjugated Estrogens—osteoporosis	0.0095	0.0149	CcSEcCtD
Terlipressin—Bradycardia—Calcium Acetate—osteoporosis	0.00916	0.0144	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00902	0.0248	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Ibandronate—osteoporosis	0.00868	0.0137	CcSEcCtD
Terlipressin—Abdominal cramps—Estradiol—osteoporosis	0.00797	0.0125	CcSEcCtD
Terlipressin—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—ADCY5—osteoporosis	0.00772	0.0212	CbGpPWpGaD
Terlipressin—Hot flush—Raloxifene—osteoporosis	0.00765	0.012	CcSEcCtD
Terlipressin—Menopausal symptoms—Raloxifene—osteoporosis	0.00758	0.0119	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—MGLL—osteoporosis	0.00699	0.0192	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Pamidronate—osteoporosis	0.0068	0.0107	CcSEcCtD
Terlipressin—AVPR2—Aquaporin-mediated transport—ADCY5—osteoporosis	0.00674	0.0185	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—PTH1R—osteoporosis	0.00641	0.0176	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CALCR—osteoporosis	0.00641	0.0176	CbGpPWpGaD
Terlipressin—Hot flush—Ethinyl Estradiol—osteoporosis	0.0064	0.0101	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—PTH—osteoporosis	0.00638	0.0175	CbGpPWpGaD
Terlipressin—Menopausal symptoms—Ethinyl Estradiol—osteoporosis	0.00634	0.00998	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00626	0.0172	CbGpPWpGaD
Terlipressin—Hypertension—Ergocalciferol—osteoporosis	0.00597	0.00939	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Estradiol—osteoporosis	0.00596	0.00937	CcSEcCtD
Terlipressin—Atrial fibrillation—Pamidronate—osteoporosis	0.00585	0.00921	CcSEcCtD
Terlipressin—Cardiac failure—Pamidronate—osteoporosis	0.00568	0.00894	CcSEcCtD
Terlipressin—Acute coronary syndrome—Estropipate—osteoporosis	0.00561	0.00883	CcSEcCtD
Terlipressin—Myocardial infarction—Estropipate—osteoporosis	0.00558	0.00878	CcSEcCtD
Terlipressin—Atrial fibrillation—Zoledronate—osteoporosis	0.00535	0.00841	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—PTHLH—osteoporosis	0.00529	0.0145	CbGpPWpGaD
Terlipressin—Skin exfoliation—Estradiol—osteoporosis	0.00514	0.00808	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00503	0.0138	CbGpPWpGaD
Terlipressin—Cardiac disorder—Estropipate—osteoporosis	0.00474	0.00746	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—CALCA—osteoporosis	0.00465	0.0128	CbGpPWpGaD
Terlipressin—Angiopathy—Estropipate—osteoporosis	0.00463	0.00729	CcSEcCtD
Terlipressin—Cardiac disorder—Raloxifene—osteoporosis	0.00459	0.00723	CcSEcCtD
Terlipressin—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.00455	0.00715	CcSEcCtD
Terlipressin—Cardiac disorder—Ibandronate—osteoporosis	0.00455	0.00715	CcSEcCtD
Terlipressin—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.00452	0.00711	CcSEcCtD
Terlipressin—Angiopathy—Raloxifene—osteoporosis	0.00449	0.00706	CcSEcCtD
Terlipressin—Malnutrition—Estropipate—osteoporosis	0.00445	0.007	CcSEcCtD
Terlipressin—Angiopathy—Ibandronate—osteoporosis	0.00444	0.00699	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—PTH1R—osteoporosis	0.00444	0.0122	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CALCR—osteoporosis	0.00444	0.0122	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—PTH1R—osteoporosis	0.00441	0.0121	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CALCR—osteoporosis	0.00441	0.0121	CbGpPWpGaD
Terlipressin—Diarrhoea—Calcium Acetate—osteoporosis	0.00437	0.00688	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00431	0.0118	CbGpPWpGaD
Terlipressin—Malnutrition—Ibandronate—osteoporosis	0.00426	0.00671	CcSEcCtD
Terlipressin—Hot flush—Estradiol—osteoporosis	0.00417	0.00657	CcSEcCtD
Terlipressin—Menopausal symptoms—Estradiol—osteoporosis	0.00414	0.00651	CcSEcCtD
Terlipressin—Vomiting—Calcium Acetate—osteoporosis	0.00406	0.00639	CcSEcCtD
Terlipressin—Nausea—Calcium Acetate—osteoporosis	0.0038	0.00597	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00376	0.00592	CcSEcCtD
Terlipressin—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00376	0.00591	CcSEcCtD
Terlipressin—Cardiac disorder—Risedronate—osteoporosis	0.00375	0.00589	CcSEcCtD
Terlipressin—Chest pain—Alendronate—osteoporosis	0.00373	0.00587	CcSEcCtD
Terlipressin—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.00371	0.00583	CcSEcCtD
Terlipressin—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.00369	0.0058	CcSEcCtD
Terlipressin—Hypertension—Ibandronate—osteoporosis	0.00368	0.00579	CcSEcCtD
Terlipressin—Chest pain—Raloxifene—osteoporosis	0.00367	0.00577	CcSEcCtD
Terlipressin—Angiopathy—Risedronate—osteoporosis	0.00366	0.00576	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00364	0.00573	CcSEcCtD
Terlipressin—Chest pain—Ibandronate—osteoporosis	0.00363	0.00571	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CALCR—osteoporosis	0.00362	0.00993	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PTH1R—osteoporosis	0.00362	0.00993	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00361	0.00567	CcSEcCtD
Terlipressin—Malnutrition—Ethinyl Estradiol—osteoporosis	0.0036	0.00567	CcSEcCtD
Terlipressin—Hypertension—Calcitriol—osteoporosis	0.0036	0.00567	CcSEcCtD
Terlipressin—Bradycardia—Zoledronate—osteoporosis	0.00357	0.00561	CcSEcCtD
Terlipressin—Cardiac disorder—Pamidronate—osteoporosis	0.00356	0.0056	CcSEcCtD
Terlipressin—Nervous system disorder—Estropipate—osteoporosis	0.00356	0.0056	CcSEcCtD
Terlipressin—Chest pain—Calcitriol—osteoporosis	0.00355	0.00559	CcSEcCtD
Terlipressin—Skin disorder—Estropipate—osteoporosis	0.00353	0.00555	CcSEcCtD
Terlipressin—Malnutrition—Risedronate—osteoporosis	0.00351	0.00553	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00348	0.00956	CbGpPWpGaD
Terlipressin—Angiopathy—Pamidronate—osteoporosis	0.00348	0.00548	CcSEcCtD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00346	0.00949	CbGpPWpGaD
Terlipressin—Nervous system disorder—Raloxifene—osteoporosis	0.00345	0.00542	CcSEcCtD
Terlipressin—Skin disorder—Raloxifene—osteoporosis	0.00341	0.00537	CcSEcCtD
Terlipressin—Nervous system disorder—Ibandronate—osteoporosis	0.00341	0.00537	CcSEcCtD
Terlipressin—Skin disorder—Ibandronate—osteoporosis	0.00338	0.00532	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—PTH—osteoporosis	0.00337	0.00923	CbGpPWpGaD
Terlipressin—Nausea—Ergocalciferol—osteoporosis	0.00335	0.00527	CcSEcCtD
Terlipressin—Malnutrition—Pamidronate—osteoporosis	0.00334	0.00526	CcSEcCtD
Terlipressin—Abdominal pain—Etidronic acid—osteoporosis	0.00332	0.00522	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—ADCY5—osteoporosis	0.00331	0.00908	CbGpPWpGaD
Terlipressin—Skin disorder—Calcitriol—osteoporosis	0.00331	0.00521	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PTH1R—osteoporosis	0.00329	0.00902	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CALCR—osteoporosis	0.00329	0.00902	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CNR2—osteoporosis	0.00328	0.009	CbGpPWpGaD
Terlipressin—Cardiac disorder—Zoledronate—osteoporosis	0.00325	0.00512	CcSEcCtD
Terlipressin—Angiopathy—Zoledronate—osteoporosis	0.00318	0.005	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Estropipate—osteoporosis	0.00313	0.00493	CcSEcCtD
Terlipressin—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00313	0.00493	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—WNT1—osteoporosis	0.00308	0.00846	CbGpPWpGaD
Terlipressin—Angiopathy—Conjugated Estrogens—osteoporosis	0.00306	0.00482	CcSEcCtD
Terlipressin—Malnutrition—Zoledronate—osteoporosis	0.00305	0.0048	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00305	0.00479	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00303	0.00478	CcSEcCtD
Terlipressin—Hypertension—Risedronate—osteoporosis	0.00303	0.00477	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.003	0.00473	CcSEcCtD
Terlipressin—Chest pain—Risedronate—osteoporosis	0.00299	0.00471	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00298	0.00819	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00297	0.00467	CcSEcCtD
Terlipressin—Acute coronary syndrome—Estradiol—osteoporosis	0.00297	0.00467	CcSEcCtD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00296	0.00813	CbGpPWpGaD
Terlipressin—Myocardial infarction—Estradiol—osteoporosis	0.00295	0.00464	CcSEcCtD
Terlipressin—Malnutrition—Conjugated Estrogens—osteoporosis	0.00294	0.00462	CcSEcCtD
Terlipressin—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00288	0.00454	CcSEcCtD
Terlipressin—Hypertension—Pamidronate—osteoporosis	0.00288	0.00454	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—MGLL—osteoporosis	0.00288	0.00789	CbGpPWpGaD
Terlipressin—Diarrhoea—Etidronic acid—osteoporosis	0.00287	0.00452	CcSEcCtD
Terlipressin—Abdominal pain—Estropipate—osteoporosis	0.00287	0.00451	CcSEcCtD
Terlipressin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00286	0.0045	CcSEcCtD
Terlipressin—Abdominal pain—Alendronate—osteoporosis	0.00283	0.00445	CcSEcCtD
Terlipressin—Nervous system disorder—Risedronate—osteoporosis	0.00281	0.00443	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—PTHLH—osteoporosis	0.00279	0.00765	CbGpPWpGaD
Terlipressin—Skin disorder—Risedronate—osteoporosis	0.00279	0.00438	CcSEcCtD
Terlipressin—Abdominal pain—Raloxifene—osteoporosis	0.00278	0.00437	CcSEcCtD
Terlipressin—Abdominal pain—Ibandronate—osteoporosis	0.00275	0.00433	CcSEcCtD
Terlipressin—Abdominal pain—Calcitriol—osteoporosis	0.00269	0.00424	CcSEcCtD
Terlipressin—Nervous system disorder—Pamidronate—osteoporosis	0.00267	0.00421	CcSEcCtD
Terlipressin—Vomiting—Etidronic acid—osteoporosis	0.00267	0.0042	CcSEcCtD
Terlipressin—Tachycardia—Pamidronate—osteoporosis	0.00266	0.00419	CcSEcCtD
Terlipressin—Hypertension—Zoledronate—osteoporosis	0.00263	0.00415	CcSEcCtD
Terlipressin—Headache—Etidronic acid—osteoporosis	0.00263	0.00413	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—MGLL—osteoporosis	0.00261	0.00717	CbGpPWpGaD
Terlipressin—Chest pain—Zoledronate—osteoporosis	0.0026	0.00409	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00258	0.00406	CcSEcCtD
Terlipressin—Dyspnoea—Risedronate—osteoporosis	0.00256	0.00402	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00254	0.004	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—POMC—osteoporosis	0.00251	0.0069	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PTH1R—osteoporosis	0.00251	0.00689	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CALCR—osteoporosis	0.00251	0.00689	CbGpPWpGaD
Terlipressin—Cardiac disorder—Estradiol—osteoporosis	0.00251	0.00394	CcSEcCtD
Terlipressin—Chest pain—Conjugated Estrogens—osteoporosis	0.0025	0.00394	CcSEcCtD
Terlipressin—Nausea—Etidronic acid—osteoporosis	0.00249	0.00392	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—PTH1R—osteoporosis	0.00249	0.00684	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CALCR—osteoporosis	0.00249	0.00684	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00248	0.00391	CcSEcCtD
Terlipressin—Diarrhoea—Estropipate—osteoporosis	0.00248	0.00391	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00248	0.0068	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Risedronate—osteoporosis	0.00248	0.0039	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CALCA—osteoporosis	0.00245	0.00674	CbGpPWpGaD
Terlipressin—Angiopathy—Estradiol—osteoporosis	0.00245	0.00386	CcSEcCtD
Terlipressin—Diarrhoea—Alendronate—osteoporosis	0.00245	0.00385	CcSEcCtD
Terlipressin—Nervous system disorder—Zoledronate—osteoporosis	0.00244	0.00384	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—POMC—osteoporosis	0.00243	0.00668	CbGpPWpGaD
Terlipressin—Dyspnoea—Pamidronate—osteoporosis	0.00243	0.00382	CcSEcCtD
Terlipressin—Tachycardia—Zoledronate—osteoporosis	0.00243	0.00382	CcSEcCtD
Terlipressin—Skin disorder—Zoledronate—osteoporosis	0.00242	0.00381	CcSEcCtD
Terlipressin—Diarrhoea—Raloxifene—osteoporosis	0.00241	0.00378	CcSEcCtD
Terlipressin—Diarrhoea—Ibandronate—osteoporosis	0.00238	0.00375	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00235	0.0037	CcSEcCtD
Terlipressin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00235	0.0037	CcSEcCtD
Terlipressin—Malnutrition—Estradiol—osteoporosis	0.00235	0.0037	CcSEcCtD
Terlipressin—Tachycardia—Conjugated Estrogens—osteoporosis	0.00234	0.00368	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—PTH—osteoporosis	0.00233	0.0064	CbGpPWpGaD
Terlipressin—Diarrhoea—Calcitriol—osteoporosis	0.00233	0.00367	CcSEcCtD
Terlipressin—Skin disorder—Conjugated Estrogens—osteoporosis	0.00233	0.00366	CcSEcCtD
Terlipressin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00233	0.00366	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—PTH—osteoporosis	0.00232	0.00635	CbGpPWpGaD
Terlipressin—Vomiting—Estropipate—osteoporosis	0.00231	0.00363	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PTH1R—osteoporosis	0.00228	0.00625	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CALCR—osteoporosis	0.00228	0.00625	CbGpPWpGaD
Terlipressin—Headache—Estropipate—osteoporosis	0.00227	0.00358	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CNR2—osteoporosis	0.00227	0.00624	CbGpPWpGaD
Terlipressin—Vomiting—Alendronate—osteoporosis	0.00227	0.00358	CcSEcCtD
Terlipressin—Abdominal pain—Risedronate—osteoporosis	0.00227	0.00357	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—PTH1R—osteoporosis	0.00226	0.00621	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CALCR—osteoporosis	0.00226	0.00621	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CNR2—osteoporosis	0.00226	0.00619	CbGpPWpGaD
Terlipressin—Headache—Alendronate—osteoporosis	0.00224	0.00352	CcSEcCtD
Terlipressin—Vomiting—Raloxifene—osteoporosis	0.00224	0.00352	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00222	0.0061	CbGpPWpGaD
Terlipressin—Dyspnoea—Zoledronate—osteoporosis	0.00222	0.00349	CcSEcCtD
Terlipressin—Vomiting—Ibandronate—osteoporosis	0.00221	0.00348	CcSEcCtD
Terlipressin—Headache—Raloxifene—osteoporosis	0.0022	0.00346	CcSEcCtD
Terlipressin—Headache—Ibandronate—osteoporosis	0.00218	0.00343	CcSEcCtD
Terlipressin—Vomiting—Calcitriol—osteoporosis	0.00217	0.00341	CcSEcCtD
Terlipressin—Nausea—Estropipate—osteoporosis	0.00216	0.00339	CcSEcCtD
Terlipressin—Abdominal pain—Pamidronate—osteoporosis	0.00216	0.00339	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00215	0.00338	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—SOST—osteoporosis	0.00215	0.00589	CbGpPWpGaD
Terlipressin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00214	0.00336	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—WNT1—osteoporosis	0.00214	0.00586	CbGpPWpGaD
Terlipressin—Headache—Calcitriol—osteoporosis	0.00213	0.00336	CcSEcCtD
Terlipressin—Nausea—Alendronate—osteoporosis	0.00212	0.00334	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—WNT1—osteoporosis	0.00212	0.00582	CbGpPWpGaD
Terlipressin—Nausea—Raloxifene—osteoporosis	0.00209	0.00329	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00207	0.00326	CcSEcCtD
Terlipressin—Nausea—Ibandronate—osteoporosis	0.00207	0.00325	CcSEcCtD
Terlipressin—Hypertension—Estradiol—osteoporosis	0.00203	0.00319	CcSEcCtD
Terlipressin—Nausea—Calcitriol—osteoporosis	0.00202	0.00318	CcSEcCtD
Terlipressin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00201	0.00317	CcSEcCtD
Terlipressin—Chest pain—Estradiol—osteoporosis	0.002	0.00315	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—MGLL—osteoporosis	0.00199	0.00547	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00199	0.00313	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—MGLL—osteoporosis	0.00198	0.00543	CbGpPWpGaD
Terlipressin—Abdominal pain—Zoledronate—osteoporosis	0.00197	0.0031	CcSEcCtD
Terlipressin—Diarrhoea—Risedronate—osteoporosis	0.00196	0.00309	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—PTH1R—osteoporosis	0.00194	0.00533	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CALCR—osteoporosis	0.00194	0.00533	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—PTHLH—osteoporosis	0.00193	0.0053	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—PTHLH—osteoporosis	0.00192	0.00527	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PTH—osteoporosis	0.0019	0.00522	CbGpPWpGaD
Terlipressin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.0019	0.00298	CcSEcCtD
Terlipressin—Nervous system disorder—Estradiol—osteoporosis	0.00188	0.00296	CcSEcCtD
Terlipressin—Tachycardia—Estradiol—osteoporosis	0.00187	0.00295	CcSEcCtD
Terlipressin—Vomiting—Ethinyl Estradiol—osteoporosis	0.00187	0.00294	CcSEcCtD
Terlipressin—Diarrhoea—Pamidronate—osteoporosis	0.00187	0.00294	CcSEcCtD
Terlipressin—Skin disorder—Estradiol—osteoporosis	0.00186	0.00293	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CNR2—osteoporosis	0.00185	0.00509	CbGpPWpGaD
Terlipressin—Headache—Ethinyl Estradiol—osteoporosis	0.00184	0.0029	CcSEcCtD
Terlipressin—Vomiting—Risedronate—osteoporosis	0.00182	0.00287	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—MGLL—osteoporosis	0.00181	0.00497	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MGLL—osteoporosis	0.0018	0.00493	CbGpPWpGaD
Terlipressin—Headache—Risedronate—osteoporosis	0.0018	0.00283	CcSEcCtD
Terlipressin—Nausea—Ethinyl Estradiol—osteoporosis	0.00175	0.00275	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—POMC—osteoporosis	0.00174	0.00478	CbGpPWpGaD
Terlipressin—Vomiting—Pamidronate—osteoporosis	0.00173	0.00273	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—POMC—osteoporosis	0.00173	0.00475	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PTH—osteoporosis	0.00173	0.00474	CbGpPWpGaD
Terlipressin—Dyspnoea—Estradiol—osteoporosis	0.00171	0.00269	CcSEcCtD
Terlipressin—Headache—Pamidronate—osteoporosis	0.00171	0.00269	CcSEcCtD
Terlipressin—Diarrhoea—Zoledronate—osteoporosis	0.0017	0.00268	CcSEcCtD
Terlipressin—Nausea—Risedronate—osteoporosis	0.0017	0.00268	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CALCA—osteoporosis	0.0017	0.00467	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CALCA—osteoporosis	0.00169	0.00464	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00169	0.00463	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CNR2—osteoporosis	0.00168	0.00462	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Estradiol—osteoporosis	0.00166	0.00261	CcSEcCtD
Terlipressin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00164	0.00258	CcSEcCtD
Terlipressin—Nausea—Pamidronate—osteoporosis	0.00162	0.00255	CcSEcCtD
Terlipressin—Vomiting—Zoledronate—osteoporosis	0.00158	0.00249	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—WNT1—osteoporosis	0.00158	0.00434	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PTHLH—osteoporosis	0.00158	0.00432	CbGpPWpGaD
Terlipressin—Headache—Zoledronate—osteoporosis	0.00156	0.00245	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—MGLL—osteoporosis	0.00154	0.00423	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00154	0.00423	CbGpPWpGaD
Terlipressin—Vomiting—Conjugated Estrogens—osteoporosis	0.00152	0.0024	CcSEcCtD
Terlipressin—Abdominal pain—Estradiol—osteoporosis	0.00152	0.00239	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—LRP5—osteoporosis	0.00151	0.00413	CbGpPWpGaD
Terlipressin—Headache—Conjugated Estrogens—osteoporosis	0.0015	0.00236	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—SOST—osteoporosis	0.00149	0.00408	CbGpPWpGaD
Terlipressin—Nausea—Zoledronate—osteoporosis	0.00148	0.00233	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—SOST—osteoporosis	0.00148	0.00406	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LRP6—osteoporosis	0.00144	0.00395	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PTHLH—osteoporosis	0.00143	0.00393	CbGpPWpGaD
Terlipressin—Nausea—Conjugated Estrogens—osteoporosis	0.00142	0.00224	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CALCA—osteoporosis	0.00139	0.00381	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CALCR—osteoporosis	0.00135	0.00369	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTH1R—osteoporosis	0.00135	0.00369	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTH1R—osteoporosis	0.00134	0.00367	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CALCR—osteoporosis	0.00134	0.00367	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PTH—osteoporosis	0.00132	0.00362	CbGpPWpGaD
Terlipressin—Diarrhoea—Estradiol—osteoporosis	0.00131	0.00207	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—PTH—osteoporosis	0.00131	0.00359	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CNR2—osteoporosis	0.00128	0.00352	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—POMC—osteoporosis	0.00128	0.00352	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CNR2—osteoporosis	0.00128	0.0035	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CALCA—osteoporosis	0.00126	0.00346	CbGpPWpGaD
Terlipressin—Vomiting—Estradiol—osteoporosis	0.00122	0.00192	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—TLN1—osteoporosis	0.00122	0.00334	CbGpPWpGaD
Terlipressin—Headache—Estradiol—osteoporosis	0.0012	0.00189	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PTH—osteoporosis	0.0012	0.00328	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTH—osteoporosis	0.00119	0.00326	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00117	0.00321	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CNR2—osteoporosis	0.00117	0.0032	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00116	0.00319	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CNR2—osteoporosis	0.00116	0.00318	CbGpPWpGaD
Terlipressin—Nausea—Estradiol—osteoporosis	0.00114	0.00179	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—WNT1—osteoporosis	0.0011	0.00301	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PTHLH—osteoporosis	0.00109	0.003	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—WNT1—osteoporosis	0.00109	0.00299	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PTHLH—osteoporosis	0.00108	0.00298	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MGLL—osteoporosis	0.00107	0.00293	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MGLL—osteoporosis	0.00106	0.00291	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—P4HB—osteoporosis	0.00105	0.00288	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LRP5—osteoporosis	0.00104	0.00286	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LRP5—osteoporosis	0.00104	0.00284	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTH—osteoporosis	0.00102	0.0028	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RAP1A—osteoporosis	0.001	0.00275	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LRP6—osteoporosis	0.000998	0.00274	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CNR2—osteoporosis	0.000994	0.00273	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PTHLH—osteoporosis	0.000992	0.00272	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LRP6—osteoporosis	0.000991	0.00272	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00099	0.00272	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—ADCY5—osteoporosis	0.000987	0.00271	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTHLH—osteoporosis	0.000985	0.0027	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NFATC1—osteoporosis	0.000978	0.00268	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—DKK1—osteoporosis	0.00097	0.00266	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CALCA—osteoporosis	0.000962	0.00264	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CALCA—osteoporosis	0.000955	0.00262	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—WNT1—osteoporosis	0.000935	0.00256	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.00093	0.00255	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGA—osteoporosis	0.000909	0.0025	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—ADCY5—osteoporosis	0.000896	0.00246	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—POMC—osteoporosis	0.00089	0.00244	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—POMC—osteoporosis	0.000884	0.00243	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CALCA—osteoporosis	0.000873	0.0024	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CALCA—osteoporosis	0.000867	0.00238	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTHLH—osteoporosis	0.000845	0.00232	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BMP2—osteoporosis	0.000845	0.00232	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TLN1—osteoporosis	0.000843	0.00231	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TLN1—osteoporosis	0.000837	0.0023	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGB—osteoporosis	0.000827	0.00227	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PSMA2—osteoporosis	0.000799	0.00219	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PSMA5—osteoporosis	0.000799	0.00219	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CALCA—osteoporosis	0.000744	0.00204	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—P4HB—osteoporosis	0.000727	0.00199	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—POMC—osteoporosis	0.000726	0.00199	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—P4HB—osteoporosis	0.000722	0.00198	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTH—osteoporosis	0.000707	0.00194	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTH—osteoporosis	0.000702	0.00193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RAP1A—osteoporosis	0.000695	0.00191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RAP1A—osteoporosis	0.00069	0.00189	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CNR2—osteoporosis	0.000689	0.00189	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000686	0.00188	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CNR2—osteoporosis	0.000684	0.00188	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—ADCY5—osteoporosis	0.000684	0.00188	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—ADCY5—osteoporosis	0.000679	0.00186	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NFATC1—osteoporosis	0.000678	0.00186	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KL—osteoporosis	0.000676	0.00185	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NFATC1—osteoporosis	0.000673	0.00185	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DKK1—osteoporosis	0.000673	0.00185	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DKK1—osteoporosis	0.000668	0.00183	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—POMC—osteoporosis	0.000659	0.00181	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—WNT1—osteoporosis	0.000648	0.00178	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—WNT1—osteoporosis	0.000643	0.00177	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6R—osteoporosis	0.000643	0.00176	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGA—osteoporosis	0.00063	0.00173	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGA—osteoporosis	0.000626	0.00172	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—ADCY5—osteoporosis	0.000621	0.0017	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—ADCY5—osteoporosis	0.000617	0.00169	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTHLH—osteoporosis	0.000586	0.00161	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BMP2—osteoporosis	0.000586	0.00161	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTHLH—osteoporosis	0.000582	0.0016	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BMP2—osteoporosis	0.000582	0.0016	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGB—osteoporosis	0.000573	0.00157	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGB—osteoporosis	0.000569	0.00156	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PSMA5—osteoporosis	0.000554	0.00152	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PSMA2—osteoporosis	0.000554	0.00152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PSMA5—osteoporosis	0.00055	0.00151	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PSMA2—osteoporosis	0.00055	0.00151	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ADCY5—osteoporosis	0.000529	0.00145	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CALCA—osteoporosis	0.000516	0.00142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SPP1—osteoporosis	0.000512	0.00141	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CALCA—osteoporosis	0.000512	0.00141	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—POMC—osteoporosis	0.000503	0.00138	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—POMC—osteoporosis	0.000499	0.00137	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KL—osteoporosis	0.000468	0.00129	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KL—osteoporosis	0.000465	0.00128	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS2—osteoporosis	0.000463	0.00127	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—POMC—osteoporosis	0.000457	0.00125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—POMC—osteoporosis	0.000454	0.00124	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—LEP—osteoporosis	0.000453	0.00124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6R—osteoporosis	0.000446	0.00122	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6R—osteoporosis	0.000442	0.00121	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ESR1—osteoporosis	0.000433	0.00119	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS1—osteoporosis	0.000404	0.00111	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—POMC—osteoporosis	0.000389	0.00107	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6R—osteoporosis	0.00038	0.00104	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1—osteoporosis	0.000375	0.00103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADCY5—osteoporosis	0.000367	0.00101	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ADCY5—osteoporosis	0.000364	0.001	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SPP1—osteoporosis	0.000355	0.000974	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SPP1—osteoporosis	0.000352	0.000967	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS2—osteoporosis	0.000321	0.000881	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS2—osteoporosis	0.000319	0.000875	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LEP—osteoporosis	0.000314	0.000862	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LEP—osteoporosis	0.000312	0.000856	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ESR1—osteoporosis	0.0003	0.000823	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ESR1—osteoporosis	0.000298	0.000817	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—osteoporosis	0.000286	0.000786	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS1—osteoporosis	0.00028	0.000769	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS1—osteoporosis	0.000278	0.000764	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—POMC—osteoporosis	0.00027	0.000741	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—POMC—osteoporosis	0.000268	0.000735	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6R—osteoporosis	0.000263	0.000722	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6R—osteoporosis	0.000261	0.000717	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1—osteoporosis	0.00026	0.000712	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1—osteoporosis	0.000258	0.000707	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—osteoporosis	0.000225	0.000618	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—osteoporosis	0.000225	0.000616	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—osteoporosis	0.000199	0.000545	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—osteoporosis	0.000197	0.000541	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—osteoporosis	0.000169	0.000464	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—osteoporosis	0.000156	0.000428	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—osteoporosis	0.000156	0.000427	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—osteoporosis	0.000155	0.000425	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—osteoporosis	0.000155	0.000424	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—osteoporosis	0.000117	0.000322	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—osteoporosis	0.000116	0.00032	CbGpPWpGaD
